2005 Annual Meeting | Management of Status Epilepticus

Date Monday 04/11/05

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) Thomas P. Bleck, MD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Upon completion:
Participants should be able to help redesign local emergency medical system protocols to improve the pre-hospital care of status epilepticus patients; better evaluate and manage patients who may be suffering from nonconvulsive status epilepticus; and apply recent information about the management of refractory status epilepticus.

CME Available No CME available

Program Level Intermediate

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:30 PM - 07:30 PM		Treatment of Nonconvulsive Status Epilepticus Nathan B. Fountain, MD, FAAN
06:30 PM - 09:30 PM		Dinner
07:30 PM - 08:15 PM		Prognosis of Various Forms of Status Epilepticus Frank W. Drislane, MD, FAAN
08:15 PM - 09:15 PM		Management of Refractory Status Epilepticus Thomas P. Bleck, MD, FAAN
09:15 PM - 09:30 PM		Questions and Answers

Faculty Disclosures
Thomas P. Bleck, MD, FAAN	Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.
Nathan B. Fountain, MD, FAAN	Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coda. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainStorm. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shackleford. Dr. Fountain has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Acumen. Dr. Fountain has stock in Hexokine.
Frank W. Drislane, MD, FAAN	No disclosure on file